via Lawson Health Research Institute
Computational analysis of epigenetic patterns facilitates diagnosis of unknown hereditary disorders
A new sophisticated computational model, developed by scientists at Lawson Health Research Institute, is bringing an innovative method of diagnosing rare hereditary conditions.
Genome-wide testing of DNA methylation, a mechanism of the epigenome, has been shown to facilitate the diagnosis of previously unsolved cases of neurodevelopmental or congenital abnormalities. The epigenome is any process that can change the expression of a gene without changing the gene sequence.
The latest in a series of research publications around the theme of epigenomic testing applied the new pattern recognition model to DNA samples of 965 patients with neurodevelopmental and congenital anomalies that did not have a definitive diagnosis despite extensive clinical genetic testing. Their DNA, acquired through blood samples, was examined using the new model, and dozens of new cases were resolved.
Current testing of patients who present with neurodevelopmental and congenital anomalies leaves a number of cases undiagnosed or unexplained. “Many families spend years going through repeated testing and assessments, in search of a diagnosis. This process is hard on patients and families, and is a great cost to our health care system,” explains Dr. Bekim Sadikovic, Associate Scientist at Lawson, and Head of the Molecular Genetics Division in the Department of Pathology and Laboratory Medicine, London Health Sciences Centre (LHSC).
While currently there are limited treatment options associated with many of these conditions, providing a specific diagnosis can help physicians better predict the course of the disease, allowing for better planning and support for the patient. This research highlights the value of epigenomic testing in the routine assessment of neurodevelopmental and congenital disorders.
From this research, LHSC will be the first site in the world to offer this type of genetic testing. “We are excited to make this testing accessible to local patients, and across the world. Our lab has partnered and licensed this technology to Greenwood Genetics Laboratories in the United States and Amsterdam University Medical Centre Laboratories in the European Union”, says Dr. Sadikovic. 100 per cent of revenue will be funneled back to support local testing for patients and ongoing research.
Learn more: Research leads to new molecular diagnostic tool
The Latest on: Molecular diagnostic tool
via Google News
The Latest on: Molecular diagnostic tool
- Ares Genetics, Belgian Infectious Disease Center Partner on Computational Dx Toolson July 26, 2022 at 7:10 am
Ares, a subsidiary of OpGen, will work with the Belgian National Reference Centre for invasive S. pneumoniae to develop the computational tools.
- Co-Diagnostics, Inc. to Announce Expansion of OEM Agreement with Bio Molecular Systems at AACCon July 26, 2022 at 7:08 am
Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it ...
- Co-Diagnostics set to expand OEM deal with Bio Molecular Systems at AACC expoon July 26, 2022 at 6:22 am
Co-Dx tests have already been sold to laboratories and distributors in over 50 countries, and with this expanded agreement we expect ...
- Research reveals molecular clues associated with traumatic brain injuryon July 24, 2022 at 12:30 pm
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known ...
- Scientists find molecular clues behind acute and chronic phases of traumatic brain injuryon July 22, 2022 at 11:30 pm
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known ...
- Infectious Disease Diagnostic Testing Market Is Set to Fly High in Years to Come with Top Countries Data | Exclusive Report Spread Across 110 Pageson July 21, 2022 at 12:18 am
Report Pages] "Infectious Disease Diagnostic Testing Market" Insights 2022 By Types (Molecular Diagnostic Test, ...
- HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attritionon July 19, 2022 at 5:01 am
TUCSON, Ariz., July 19, 2022 (GLOBE NEWSWIRE) -- (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today ...
- R-Biopharm starts marketing the RIDAUNITY system for real-time PCR in molecular diagnostic laboratorieson July 18, 2022 at 10:59 pm
R-Biopharm starts commercialization of the RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories. NEWS AKTUELL // Darmstadt, July 19, 2022 – ...
- Molecular Diagnostics Market 2021 : Key Players, SWOT Analysis, Key Indicators, Forecast and COVID 19 Impact Analysis 2028on July 18, 2022 at 12:09 am
Molecular diagnostics primarily refers to the class ... The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research ...
- Molecular Diagnostics Market Estimated to Rise Profitably during the Foreseeable Futureon July 14, 2022 at 12:00 am
Molecular diagnostics primarily refers to the class ... The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research ...
via Bing News